Skip to Content

During the funding lapse, is not being supported. If data feeds are not available from GPO, will not be updated, so please use the official edition of the Federal Register on Govinfo ( If there is a technical issue with the Public Inspection List, you can view the documents on public inspection at our office in Washington, DC or on


National Institutes of Health Guidelines for Research Using Human Pluripotent Stem Cells

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Notice; withdrawal of NIH Guidelines for Research Using Pluripotent Stem Cells Derived from Human Embryos (published August 25, 2000, 65 FR 51976, corrected November 21, 2000, 65 FR 69951).


The National Institutes of Health (NIH) announces the withdrawal of those sections of the NIH Guidelines for Research Using Human Pluripotent Stem Cells,​news/​stemcell/​stemcellguidelines.htm. (NIH Guidelines), that pertain to research involving human pluripotent stem cells derived from human embryos that are the result of in vitro fertilization, are in excess of clinical need, and have not reached the stage at which the mesoderm is formed.

The President has determined the criteria that allow Federal funding for research using existing embryonic stem cell lines,​news/​releases/​2001/​08/​print/​20010809-1.html. Thus, the NIH Guidelines as they relate to human pluripotent stem cells derived from human embryos are no longer needed.

Start Further Info


NIH Office of Extramural Research, NIH, 1 Center Drive, MSC 0152, Building 1, Room 146, Bethesda, MD 20892, or e-mail

Start Signature

Dated: November 2, 2001.

Ruth L. Kirschstein,

Acting Director, National Institutes of Health.

End Signature End Further Info End Preamble

[FR Doc. 01-28426 Filed 11-13-01; 8:45 am]